Compare ALEMBIC LTD with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs SUN PHARMA - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD SUN PHARMA ALEMBIC LTD/
SUN PHARMA
 
P/E (TTM) x 70.0 22.3 313.6% View Chart
P/BV x 2.9 2.6 109.3% View Chart
Dividend Yield % 0.4 0.6 58.4%  

Financials

 ALEMBIC LTD   SUN PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
SUN PHARMA
Mar-19
ALEMBIC LTD/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs72679 10.6%   
Low Rs34375 9.0%   
Sales per share (Unadj.) Rs4.7121.1 3.9%  
Earnings per share (Unadj.) Rs6.113.4 45.6%  
Cash flow per share (Unadj.) Rs6.220.7 30.2%  
Dividends per share (Unadj.) Rs0.202.75 7.3%  
Dividend yield (eoy) %0.40.5 72.4%  
Book value per share (Unadj.) Rs40.7172.6 23.6%  
Shares outstanding (eoy) m267.032,399.26 11.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.34.4 258.9%   
Avg P/E ratio x8.739.4 22.0%  
P/CF ratio (eoy) x8.525.5 33.3%  
Price / Book Value ratio x1.33.1 42.6%  
Dividend payout %3.320.6 15.9%   
Avg Mkt Cap Rs m14,1391,264,650 1.1%   
No. of employees `000NA17.5 0.0%   
Total wages/salary Rs m20759,671 0.3%   
Avg. sales/employee Rs ThNM16,608.1-  
Avg. wages/employee Rs ThNM3,409.6-  
Avg. net profit/employee Rs ThNM1,833.8-  
INCOME DATA
Net Sales Rs m1,255290,659 0.4%  
Other income Rs m37010,255 3.6%   
Total revenues Rs m1,625300,914 0.5%   
Gross profit Rs m11163,076 0.2%  
Depreciation Rs m3817,533 0.2%   
Interest Rs m25,553 0.0%   
Profit before tax Rs m44250,246 0.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m0-12,144 0.0%   
Tax Rs m246,009 0.4%   
Profit after tax Rs m1,63032,093 5.1%  
Gross profit margin %8.921.7 40.8%  
Effective tax rate %5.412.0 45.3%   
Net profit margin %129.811.0 1,176.0%  
BALANCE SHEET DATA
Current assets Rs m1,867310,692 0.6%   
Current liabilities Rs m591173,396 0.3%   
Net working cap to sales %101.647.2 215.2%  
Current ratio x3.21.8 176.3%  
Inventory Days Days9499 95.2%  
Debtors Days Days74112 65.9%  
Net fixed assets Rs m1,791232,477 0.8%   
Share capital Rs m5342,399 22.3%   
"Free" reserves Rs m10,324411,691 2.5%   
Net worth Rs m10,858414,091 2.6%   
Long term debt Rs m4115,226 0.3%   
Total assets Rs m11,591646,938 1.8%  
Interest coverage x260.910.0 2,596.0%   
Debt to equity ratio x00 10.3%  
Sales to assets ratio x0.10.4 24.1%   
Return on assets %14.15.8 241.9%  
Return on equity %15.07.8 193.7%  
Return on capital %15.210.2 149.4%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m1966,025 0.0%   
Fx outflow Rs m26438,610 0.7%   
Net fx Rs m-24427,415 -0.9%   
CASH FLOW
From Operations Rs m23621,965 1.1%  
From Investments Rs m-224-6,813 3.3%  
From Financial Activity Rs m-27-27,305 0.1%  
Net Cashflow Rs m-15-8,442 0.2%  

Share Holding

Indian Promoters % 64.0 63.7 100.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 5.1 3.9%  
FIIs % 9.7 23.0 42.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 8.3 314.5%  
Shareholders   54,701 133,026 41.1%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   GLENMARK PHARMA  FULFORD INDIA  WYETH LTD  AJANTA PHARMA  UNICHEM LAB  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 271 Points Higher; Capital Goods and Realty Stocks Rally(Closing)

Indian share markets witnessed buying interest during closing hours today and ended higher. Benchmark indices regained momentum amid huge buying seen in capital goods and realty stocks.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market(Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys(The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jan 23, 2020 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS